Wipro Gains Over 4% After Revealing Collaboration With Transcell Oncologics For Vaccine Safety Assessment

INSUBCONTINENT EXCLUSIVE:
Shares of Wipro were last trading 4.16per cent higher at Rs 511.20 on the BSE.Share price of IT major Wipro Limited gained around five per
On Thursday, Wipro opened on the BSE at Rs 496.90, witnessing an intra day high of Rs 514.85 and an intra day low of Rs 487.45, in the
trading session so far
According to a regulatory filing by the software major to the BSE, Wipro announced its partnership with Transcell in order to strengthen
researchers have new and completely viable solution by using Wipro's technology
The technology can also be integrated into an existing workflow, including batchwise release, quality control tests in vaccine production,
and any other safety evaluation assays.On the NSE, Wipro opened at Rs 493.70, registering an intra day high of Rs 514.80 and an intra day
low of Rs 487.25, in the session so far
BSE.